Compare Medtronic PLC (MDT) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Summit Therapeutics Inc — how do they compare? Medtronic PLC trades at $82.79 (market cap $106.61B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Medtronic PLC is far larger — about 10.2× Summit Therapeutics Inc's market cap, and Medtronic PLC pays a 3.46% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| MDT | SMMT | |
|---|---|---|
Market Cap | $106.61B | $10.48B |
Sector | Health | Health |
52-Week High | $105.35 | $29.32 |
52-Week Low | $73.75 | $13.05 |
Enterprise Value | $125.36B | $9.90B |
Dividend Yield | 3.46% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
